I think the FDA reclassification will help EKSO. Short term I can see why you would think it would hurt by making it easier for competitors to compete with the GT, but I don't think that's the whole picture.
Ekso has multiple suits under development that might benefit from these changes.
Additionally, in terms of safety - I think the cream rises to the top. If a suit gets approved where people get injured, they won't last long just given market interaction.
This tech is so new not many do know. IT will be one of the big money makers for decade ahead as it becomes common in so many way. Manufacturing, Rehab, Military. There will be more then one player when market is worth billions. They need to have FDA set standards it is so new.
News 
Market Data 
Discover 
